ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex Inc's (NASDAQ:ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, ...
Two executives of a Colorado-based medical device company are still awaiting their day in court. Former Zynex CEO 67-year-old Thomas Sandgaard of Castle Rock and former COO 39-year-old Anna Lucsok of ...
Zynex Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights NEW YORK, March 04, 2026 (GLOBE ...
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors concerning the Company’s possible ...
Getting your Trinity Audio player ready... Two former executives at a Colorado-based medical device company last month were charged in connection with orchestrating an alleged health care fraud scheme ...
or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...
Hosted on MSN
Here’s Why Zynex (ZYXI) Fell in Q1
Rewey Asset Management, an investment management company, released its “RAM Smid Composite” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The composite declined 6.97 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results